Skip to content

PET/CT Study in the Diagnosis of Coronary Plaque

Comparison of Cardiac Positron Emission Tomography/Computed Tomography (PET/CT) With Coronary Angiography (CA) and Intravascular Ultrasound (IVUS) in the Diagnosis and Characterization of Coronary Artery Plaque

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00850473
Acronym
PET/CT
Enrollment
3
Registered
2009-02-25
Start date
2007-10-31
Completion date
2009-09-30
Last updated
2018-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Catheterization, Coronary Artery Disease, Myocardial Infarction

Keywords

PET, CT, Heart Attack, Coronary Artery disease, Cardiac Catheterization

Brief summary

This study is being done to determine if a picture taking test of the heart, positron emission tomography/computed tomography (or cardiac PET/CT), can identify the blockages in the heart arteries that lead to heart attacks when compared to the standard of heart catheterization.

Detailed description

Heart catheterization, in which a thin plastic tube, or catheter, is placed into an artery in the arm or leg and advanced into the heart arteries, is the procedure that you and your doctor have decided to pursue to look for heart artery blockages. It is being performed as part of your standard care and not for research purposes. The research procedure (cardiac PET/CT), which will be performed at a later date is a combination of heart CT (a test that involves the use of x-rays to identify heart artery blockages) and heart PET (an imaging test that uses a radioactive drug to look at how the heart uses fuel (sugar and fats) These tests will be combined (PET/CT) to look for the presence and type of blockage in your heart arteries. It is important to develop a test that can determine if and what type of blockage you have in your heart arteries as the presence and type of heart artery blockage is a very important predictor of heart attack and death from heart attack.

Interventions

DIAGNOSTIC_TESTPET/CT

Patient will have one imaging modality - a Positron Emitting Tomography CT which includes F-18 FDG and heparin/intralipid infusion and Contrast Dye.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years oof age or older * referred for cardiac catheterization. * coronary artery disease that does not need angioplasty.

Exclusion criteria

* history of cardiac stents * bypass surgery * bad kidney function * unable to take beta blocker medication * history of asthma * allergies to egg containing products * atrial fibrillation * pregnancy * breastfeeding * overweight by definition of a BMI over 35.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Clear Anatomical Landmarks Confirmed by CTDuring PET CT scan, an average of 2 hoursCoronary FDG uptake will be measured at the site of coronary stenosis. The target coronary stenosis will be identified by its proximity to a clear anatomical landmark seen on CT and conventional angiography.

Countries

United States

Participant flow

Participants by arm

ArmCount
Positron Emitting Image, F18 FDG, Contrast Dye
Patient will have a PET/CT imaging study to determine cardiac stenosis, patient will have an injection of F18 FDG to determine the metabolic uptake of the radio-isotope, patient will have contrast dye injected to better visualize the coronary arteries.
3
Total3

Baseline characteristics

CharacteristicPositron Emitting Image, F18 FDG, Contrast Dye
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
3 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
3 Participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 3
other
Total, other adverse events
0 / 3
serious
Total, serious adverse events
0 / 3

Outcome results

Primary

Number of Participants With Clear Anatomical Landmarks Confirmed by CT

Coronary FDG uptake will be measured at the site of coronary stenosis. The target coronary stenosis will be identified by its proximity to a clear anatomical landmark seen on CT and conventional angiography.

Time frame: During PET CT scan, an average of 2 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Positron Emitting ImageNumber of Participants With Clear Anatomical Landmarks Confirmed by CT3 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026